Skip to main content
Header image

Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system - Single centre study

KLOS, D., J. RISKO, D. KRIVACKOVA, M. LOVECEK, P. SKALICKÝ, C. NEORAL, B. MELICHAR, B. MOHELNÍKOVÁ DUCHOŇOVÁ, R. LEMSTROVÁ
Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system - Single centre study. European Journal of Surgical Oncology. 2020, 46(4 Pt A), 607-612, ISSN: 0748-7983, PMID: 31982207,  PDF.